“…A total of 11 reviews related to cancer were identified, including NMAs of interventions for gastrointestinal cancer, pancreatic cancer, acute promyelocytic leukemia non-small cell lung cancer, neurotoxicity from chemotherapy, and cancer-related fatigue [37,54,66,74,82,89,95,105,107,112,113]. Osteoarthritis (including prostatitis) was the subject of 10 reviews [28-30, 40, 42, 73, 78, 101, 103, 114], gastrointestinal infections/disorders were the subject of 6 reviews [61,64,65,67,68,115], cardiovascular disease in 4 reviews [46,69,99,102], topics related to pregnancy, childbirth and newborn health in 4 reviews [47,62,71,83], and a variety of other clinical indications were assessed in 3 or fewer reviews. The number of NMAs overall increased notably from earlier to later years.…”